A method for extracting and purifying dioscorea alkaloid compounds from Dictamni cortex and its application in anti-MRSA
Through the ethyl acetate soaking and chromatography column gradient elution technology of white fresh peel, high-purity white fresh alkali and 8-hydroxy white fresh alkali were successfully extracted, solving the extraction problems in the prior art and demonstrating them in antibacterial agents. The significant inhibitory activity on MRSA has potentially led value for antibacterial drugs.
Patent Information
- Application Number
- CN202210532638.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-05-13
- Publication Date
- 2024-11-08
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure CN114891010B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of difficile compound extraction, and particularly relates to a method for extracting and purifying difficile compounds in difficile cortex and an application thereof in resisting MRSA. Background Art
[0002] In recent years, with the continuous improvement of the world's medical technology, more and more diseases have been conquered by humans. However, with the overuse of antibiotics and other drugs, many different types of bacteria have developed certain drug resistance, making it more difficult to treat after infection, and sometimes even impossible to treat. According to statistics from the World Health Organization, about 700,000 people die each year worldwide due to bacterial resistance. Bacterial resistance is currently becoming a major challenge in the field of global public health and a focus of attention in the medical industry of various countries. Therefore, the development of new drugs with good broad-spectrum antibacterial activity has become an urgent problem to be solved in clinical practice.
[0003]
[0004] Structural formula of distilled water compounds (distilled water: R = -H; 8-hydroxy distilled water: R = -OH)
[0005] Dictamnin and 8-hydroxydictamnin are a kind of Dictamnin compounds from natural plants, which have the structural characteristics of furanoquinoline structure and are mainly extracted from the peel of Dictamnin.
[0006] At present, there have been many studies on the extraction of diffusin compounds. However, how to use a simpler and more effective method to extract high-purity diffusin compounds deserves further study. Summary of the invention
[0007] Purpose of the invention: In view of the problems existing in the prior art, the present invention provides a method for extracting and purifying dioscorea alkaloids from Dictamni cortex, which is simple and effective, and the obtained product has high purity.
[0008] Technical solution: In order to achieve the above-mentioned invention object, the technical solution adopted by the present invention is as follows:
[0009] A method for extracting and purifying dioscorea alkaloid compounds in Dictamni cortex comprises the following steps:
[0010] (1) After the Dictamni cortex is crushed, it is soaked in ethyl acetate, and then a sufficient amount of ethyl acetate is added for reflux extraction, the extracts are combined, cooled and concentrated, and after the ethyl acetate is completely removed, a crude extract is obtained;
[0011] (2) adding sample-mixing silica gel to the extract, drying it, preparing a chromatography column, using a mixed eluent of petroleum ether and acetone for gradient elution, comparing the collected sample with a standard product, and separating distilled water and crude 8-hydroxy distilled water;
[0012] (3) Recrystallizing the crude products of distilled spirit and 8-hydroxy distilled spirit to obtain pure products of distilled spirit and 8-hydroxy distilled spirit.
[0013] The obtained pure distilled water and 8-hydroxy distilled water were identified and their chemical structures are shown below:
[0014]
[0015] Preferably, in step (1), in the reflux extraction, the solid-liquid ratio of Dictamni cortex to ethyl acetate is 1:(5-7), and the reflux extraction is performed 4-6 times, each time for 50-70 minutes.
[0016] Preferably, in step (1), the concentration is carried out by a vacuum filtration method.
[0017] Preferably, in step (2), the chromatography column is prepared by wet column packing and dry sample loading.
[0018] Preferably, in step (2), the petroleum ether and acetone mixed eluent is used for gradient elution, and the gradient is set as follows:
[0019] The volume ratios of petroleum ether:acetone are 20:1, 17:1, 14:1, 11:1, 8:1, 5:1, and 3:1, respectively.
[0020] Preferably, in step (2), the collected sample is compared with a standard product and a TLC detection method is used to compare the collected sample with pure products of distilled water and 8-hydroxy distilled water.
[0021] Preferably, in step (3), crude distilled water and 8-hydroxy distilled water are recrystallized in acetone.
[0022] The invention also provides application of the prepared distilled sugar or 8-hydroxy distilled sugar in preparing an antibacterial agent.
[0023] Furthermore, the present invention provides the use of the distilled water or 8-hydroxy distilled water in the preparation of drugs against Staphylococcus aureus, methicillin-resistant Staphylococcus aureus or Escherichia coli.
[0024] The antibacterial activity evaluation by the microbroth dilution method shows that the distilled water and 8-hydroxy distilled water prepared by the present invention exhibit good inhibitory activity against Staphylococcus aureus, and the MIC of distilled water to clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) is between 16 and 128 μg / mL; the minimum inhibitory concentration (MIC) of 8-hydroxy distilled water to standard Staphylococcus aureus 29213 and standard Escherichia coli 25922 is between 64 and 128 μg / mL.
[0025] Technical effect: Compared with the prior art, the extraction and purification method of the present invention has a simple process and low cost, and can effectively extract the diffusin compounds diffusin and 8-hydroxy diffusin at the same time. The obtained products have high purity, which can be as high as 95% or more. In addition, the obtained diffusin and 8-hydroxy diffusin have been confirmed by experiments to be effective antibacterial, and have good antibacterial effects on Staphylococcus aureus or Escherichia coli, especially on MRSA. Therefore, the diffusin and 8-hydroxy diffusin of the present invention are expected to be further studied as new antibacterial leads, and are of great significance for the discovery of new anti-resistant bacteria leads. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 The figure is the hydrogen nuclear magnetic spectrum of dioscorea alkali of the present invention.
[0027] Figure 2 The figure is the carbon-NMR spectrum of dioscorea alkali of the present invention.
[0028] Figure 3 The figure is the hydrogen nuclear magnetic spectrum of 8-hydroxydandruffine of the present invention. DETAILED DESCRIPTION
[0029] The present invention is further described in detail below through examples.
[0030] Example 1 Preparation of dioscorea alkali
[0031] 5 kg of Dictamni cortex was crushed and soaked with ethyl acetate. The mixture was refluxed and extracted for 5 times (each time for 1 hour) at a liquid-to-solid ratio of 1:6 (Dictamni cortex: ethyl acetate). The ethyl acetate was removed by concentration under reduced pressure. The obtained extract was added to sample-mixed silica gel and then spin-dried. Column chromatography was performed by wet column loading and dry loading. Gradient elution was performed using an eluent [petroleum ether: acetone (v / v) ratio of 20:1, 17:1, 14:1, 11:1, 8:1, 5:1, 3:1, respectively]. At the same time, TLC detection was compared with the standard product. The eluates were combined according to the TLC detection results, spin-dried, and recrystallized using acetone to obtain a pure Dictamni alkali product with a purity of 96%.
[0032] Physicochemical properties of dioscorea:
[0033] 1) Yellow crystals, melting point 133-134°C.
[0034] 2) The NMR spectrum of the compound ( 1 H / 13 C NMR, 400MHz) characteristics:
[0035] Deuterated chloroform was used as solvent and TMS was used as internal standard. The peaks were assigned as follows: 1 H NMR (400 MHz CDCl 3 )δ:8.26(dd,J=8.4,1.2Hz,1H,H-8),8.00(d,1H,J=8.4Hz,H-5),7.66-7.70(m,1H,H-7),7.6 2(d,1H,J=2.8Hz,H-2),7.46-7.42(m,1H,H-6),7.07(d,1H,J=2.8Hz,H-3),4.44(s,3H,-OCH 3 ); 13 C NMR (100MHz CDCl 3 )δ:163.80,156.86,145.59,143.55,129.62,127.77,123.73,122.37,118.69,104.75,103.41,59.01.
[0036] Example 2 Preparation of 8-hydroxydandruff
[0037] 5 kg of Dictamni cortex was crushed and soaked with ethyl acetate. The mixture was refluxed and extracted for 5 times (each time for 1 hour) at a liquid-to-solid ratio of 1:6 (Dictamni cortex: ethyl acetate). The ethyl acetate was removed by concentration under reduced pressure. The obtained extract was added to sample-mixed silica gel and then spin-dried. Column chromatography was performed by wet column loading and dry loading. Gradient elution was performed using an eluent [petroleum ether: acetone (v / v) ratio of 20:1, 17:1, 14:1, 11:1, 8:1, 5:1, 3:1, respectively]. At the same time, TLC detection was compared with the standard product. The eluates were combined according to the TLC detection results, spin-dried, and recrystallized using acetone to obtain pure 8-hydroxydictamni alkaloid with a purity of 97%.
[0038] The physicochemical properties of compound 2 are as follows:
[0039] 1) White crystals, melting point 148-149℃.
[0040] 2) The NMR spectrum of the compound ( 1 H NMR, 400 MHz) characteristics:
[0041] Deuterated chloroform was used as solvent and TMS was used as internal standard. The peaks were assigned as follows: 1 H NMR (400 MHz CDCl 3)δ:7.71-7.74(m,2H,-OH and H-5),7.61(d,1H,J=2.8Hz,H-2),7.31-7.35(m,1H,H-6),7.17(dd,1H,J=7.6,1.2Hz,H-4),7.09(d,1H,J=2.8Hz,H-3),4.44(s,3H,-OCH 3 ).
[0042] Application Example 1: In vitro antibacterial activity assay
[0043] 1. Test bacteria:
[0044] Staphylococcus aureus (S. aureus ATCC 29213); Escherichia coli (E.coil ATCC 25922); MRSA11-23 (clinical isolates)
[0045] 2. Samples and reagents:
[0046] The samples are: distilled water and 8-hydroxy distilled water prepared in the examples.
[0047] 3. Test method:
[0048] The in vitro antibacterial activity of the products of the present invention, damascene and 8-hydroxydamascene, was tested by the microbroth dilution method on a 96-well plate. The colonies were picked up with an inoculation loop and inoculated into 5 mL of water casein broth medium and cultured at 37°C for 2-6 hours. After the number of bacteria increased, the concentration was corrected to 0.5 McFarland turbidity tube standard with MHB broth, containing about 1-2×10 8CFU / mL. Dilute the above bacterial suspension 1:100 with MHB broth for later use. Weigh 2.56 mg of the sample, dissolve it in 200 μL DMSO, and then dilute it 50 times with MHB broth or saline to obtain a sample stock solution. Take a sterile 96-well plate, add 200 μL of antibacterial drugs to the first well with a liquid gun, add 100 μL of MHB broth culture medium to each of the 2nd to 10th wells, take 100 μL from the 1st well and add it to the 2nd well to mix, then take 100 μL from the 2nd well and add it to the 3rd well, and so on. Take 100 μL from the 10th well and discard it. At this time, the drug concentrations in each well are 256, 128, 64, 32, 16, 8, 4, 2, 1, and 0.5 μg / mL, respectively. Add 200 μL of bacterial solution to the 11th well as a positive control, add 200 μL of MHB broth medium to the 12th well as a negative control, and then add 100 μL of the previously prepared bacterial solution to each of the 1st to 10th wells, so that the drug concentrations of the 1st to 10th wells are 128, 64, 32, 16, 8, 4, 2, 1, 0.5, and 0.25 μg / mL, respectively. Place the inoculated 96-well plate in a 37°C incubator for 16 to 20 hours and observe the results. Use an enzyme-labeled analyzer to measure the OD value of each well at 600 nm, and use the naked eye to observe the drug concentration of the completely clear well as the MIC value.
[0049] Table 1. In vitro antibacterial activity of dioscorea alkali and 8-hydroxy dioscorea alkali of the present invention (μg / mL)
[0050]
[0051]
[0052] a ND: Not tested
[0053] From Table 1, it can be concluded that the dijucinone and 8-hydroxy dijucinone prepared by the present invention both exhibit certain antibacterial activity against Staphylococcus aureus and Escherichia coli, and the minimum inhibitory concentration (MIC) is between 64-128 μg / mL, reflecting potential broad-spectrum antibacterial properties. Therefore, the dijucinone and 8-hydroxy dijucinone prepared by the present invention are expected to be used to prepare potential antibacterial drug lead molecules.
[0054] Table 2. Anti-MRSA activity of dioscorea alkaloids and 8-hydroxy dioscorea alkaloids of the present invention (μg / mL)
[0055]
[0056] As can be seen from Table 2, the dijucinone and 8-hydroxy dijucinone prepared by the present invention have certain inhibitory activity against clinically isolated MRSA strains, and the MIC value is 16-128 μg / mL. Compared with the dijucinone extract, the monomer dijucinone has good anti-MRSA activity, wherein the minimum inhibitory concentration for clinically isolated strain M-14 is 16 μg / mL. In summary, the dijucinone and 8-hydroxy dijucinone prepared by the present invention have good anti-MRSA activity, and are expected to be used as the lead molecule for the preparation of new antibacterial drugs, and further in-depth research is performed for structural optimization.
Claims
1. A method for extracting and purifying dioscorea alkaloid compounds from Dictamni cortex, characterized in that: The following steps are involved: (1) After the Dictamni cortex is crushed, it is soaked in ethyl acetate, and then a sufficient amount of ethyl acetate is added for reflux extraction, the solid-liquid ratio of the Dictamni cortex to ethyl acetate is 1:(5-7), and the reflux extraction is performed 4-6 times, each time for 50-70 minutes, the extracts are combined, cooled and concentrated, and after the ethyl acetate is completely removed, a crude extract is obtained; (2) adding sample-mixing silica gel to the extract, drying it, preparing a chromatography column, and performing gradient elution using a mixed eluent of petroleum ether and acetone, wherein the gradient is set as follows: the volume ratio of petroleum ether to acetone is 20:1, 17:1, 14:1, 11:1, 8:1, 5:1, and 3:1, respectively; comparing the collected sample with the standard product, separating and obtaining crude distilled water and 8-hydroxy distilled water; (3) Recrystallizing the crude products of distilled spirit and 8-hydroxy distilled spirit in acetone to obtain pure products of distilled spirit and 8-hydroxy distilled spirit.
2. The method for extracting and purifying dioscorea alkaloids in the Cortex Dictamni according to claim 1, wherein: In step (1), the concentration is carried out by a vacuum filtration method.
3. The method for extracting and purifying dioscorea alkaloids in the Cortex Dictamni according to claim 1, wherein: In step (2), the chromatography column is prepared by wet column packing and dry sample loading.
4. The method for extracting and purifying dioscorea alkaloids in the Cortex Dictamni according to claim 1, wherein: In step (2), the collected sample is compared with a standard product and a TLC detection method is used to compare the sample with the pure products of distilled water and 8-hydroxy distilled water.
Citation Information
Patent Citations
Application of dictamine in preparation of anti candida albicans drugs
CN104248637A
Method for separation and enrichment of furoquinoline alkaloid in dictamnus angustifolius
CN107629065A
Method for extracting fraxinellone from cortex dictamni
CN109824638A
Inhibitor for urinary tract infection pathogen urinary tract pathogenic escherichia coli
CN114246868A
